au.\*:("PARHAM, C. S")
Results 1 to 15 of 15
Selection :
Preconditioning is not abolished by the delayed rectifier K+ blocker dofetilideGROVER, G. J; D'ALONZO, A. J; DZWONCZYK, S et al.American journal of physiology. Heart and circulatory physiology. 1996, Vol 40, Num 3, pp H1207-H1214, issn 0363-6135Article
The combined antiischemic effects of the thromboxane receptor antagonist SQ 30,741 and tissue-type plasminogen activatorGROVER, G. J; PARHAM, C. S; SCHUMACHER, W. A et al.The American heart journal. 1991, Vol 121, Num 2, pp 426-433, issn 0002-8703, 8 p., p.1Article
The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogsGROVER, G. J; DZWONCZYK, S; PARHAM, C. S et al.Cardiovascular drugs and therapy. 1990, Vol 4, Num 2, pp 465-474, 10 p.Article
Cardioprotection with the KATP opener cromakalin is not correlated with ischemic myocardial action potential durationGROVER, G. J; D'ALONZO, A. J; PARHAM, C. S et al.Journal of cardiovascular pharmacology. 1995, Vol 26, Num 1, pp 145-152, issn 0160-2446Article
Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogsSAINI, R. K; FULMOR, I. E; PARHAM, C. S et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 237, Num 1, pp 1-8, issn 0022-3565Article
The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusionGROVER, G. J; DZWONCZYK, S; PARHAM, C. S et al.Cardiovascular research. 1993, Vol 27, Num 9, pp 1613-1618, issn 0008-6363Article
The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacin-induced ischemiaGROVER, G. J; PARHAM, C. S.European journal of pharmacology. 1987, Vol 143, Num 1, pp 109-117, issn 0014-2999Article
Role of thromboxane A2 in the control pf myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemiaGROVER, G. J; PARHAM, C. S.Circulation research. 1989, Vol 64, Num 3, pp 575-582, issn 0009-7330Article
Pharmacologic profile of the dihydropyrimidine calcium channel blockers SQ 32,547 and SQ 32,946GROVER, G. J; DZWONCZYK, S; MCMULLEN, D. M et al.Journal of cardiovascular pharmacology. 1995, Vol 26, Num 2, pp 289-294, issn 0160-2446Article
Effects of intracoronary cromakalim on postischaemic contractile function and action potential durationD'ALONZO, A. J; DARBENZIO, R. B; PARHAM, C. S et al.Cardiovascular research. 1992, Vol 26, Num 11, pp 1046-1053, issn 0008-6363Article
The cardioprotective effects of the thromboxane receptor antagonist SQ 31,741 are not reversed by aspirinGROVER, G. J; PARHAM, C. S; SCHUMACHER, W. A et al.Basic research in cardiology. 1991, Vol 86, Num 2, pp 99-106, issn 0300-8428, 8 p.Article
Anti-ischemic and vasorelaxant effects of the new benzazepine calcium channel blocker SQ 31,765GROVER, G. J; PARHAM, C. S; SLEPH, P. G et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 251, Num 3, pp 1020-1025, issn 0022-3565Article
Nicorandil improves postischemic contractile function independently of direct myocardial effectsGROVER, G. J; SLEPH, P. G; PARHAM, C. S et al.Journal of cardiovascular pharmacology. 1990, Vol 15, Num 5, pp 698-705, issn 0160-2446Article
Anti-ischemic activity of the novel benzazepine calcium antagonist SQ 31,486GROVER, G. J; SLEPH, P. G; PARHAM, C. S et al.Journal of cardiovascular pharmacology. 1990, Vol 16, Num 2, pp 219-227, issn 0160-2446, 9 p.Article
Effect of diltiazem on infarct size, reperfusion flow and flow reserve: the effect of timing of treatmentGROVER, G. J; SLEPH, P. G; PARHAM, C. S et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 1, pp 263-269, issn 0022-3565Article